Historically, methadone was the only pharmacologic treatment in the United States for pregnant women with opioid addiction; however, it was rewtricted to use exclusively in federally licensed facilities, thus making access to care and therapy challenging (Jones & Fiellin , 2007; Pritham, Troese,& Stetson 2007).